ATE239006T1 - Verbindungen der neuraminsaeure - Google Patents

Verbindungen der neuraminsaeure

Info

Publication number
ATE239006T1
ATE239006T1 AT97934769T AT97934769T ATE239006T1 AT E239006 T1 ATE239006 T1 AT E239006T1 AT 97934769 T AT97934769 T AT 97934769T AT 97934769 T AT97934769 T AT 97934769T AT E239006 T1 ATE239006 T1 AT E239006T1
Authority
AT
Austria
Prior art keywords
hydrogen atom
acid compound
group
neuraminic acid
neuramine
Prior art date
Application number
AT97934769T
Other languages
German (de)
English (en)
Inventor
Takeshi Honda
Yoshiyuki Kobayashi
Makoto Yamashita
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Application granted granted Critical
Publication of ATE239006T1 publication Critical patent/ATE239006T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Cephalosporin Compounds (AREA)
AT97934769T 1996-08-13 1997-08-12 Verbindungen der neuraminsaeure ATE239006T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP21345696 1996-08-13
PCT/JP1997/002810 WO1998006712A1 (en) 1996-08-13 1997-08-12 Neuraminic acid compounds

Publications (1)

Publication Number Publication Date
ATE239006T1 true ATE239006T1 (de) 2003-05-15

Family

ID=16639524

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97934769T ATE239006T1 (de) 1996-08-13 1997-08-12 Verbindungen der neuraminsaeure

Country Status (17)

Country Link
EP (1) EP0934939B1 (enExample)
KR (1) KR100526666B1 (enExample)
CN (1) CN1126752C (enExample)
AT (1) ATE239006T1 (enExample)
AU (1) AU723994B2 (enExample)
CA (1) CA2263336C (enExample)
CZ (1) CZ293041B6 (enExample)
DE (1) DE69721553T2 (enExample)
DK (1) DK0934939T3 (enExample)
ES (1) ES2198002T3 (enExample)
HU (1) HU226130B1 (enExample)
IL (1) IL128358A (enExample)
NO (1) NO319321B1 (enExample)
NZ (1) NZ334101A (enExample)
PT (1) PT934939E (enExample)
RU (1) RU2169145C2 (enExample)
WO (1) WO1998006712A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6518305B1 (en) 1998-04-23 2003-02-11 Abbott Laboratories Five-membered carbocyclic and heterocyclic inhibitors of neuraminidases
US6593314B1 (en) 1999-10-19 2003-07-15 Abbott Laboratories Neuraminidase inhibitors
AU2001252578A1 (en) * 2000-04-25 2001-11-07 Sankyo Company Limited Preventives for influenza
AUPR001000A0 (en) 2000-09-08 2000-10-05 Biota Scientific Management Pty Ltd Novel chemical compounds and their use
WO2002076980A1 (en) * 2001-03-27 2002-10-03 Sankyo Company, Limited Sialic acid derivatives
WO2002092555A1 (en) * 2001-05-11 2002-11-21 Sankyo Company, Limited Sialic acid derivatives
ATE399779T1 (de) * 2001-09-07 2008-07-15 Biota Scient Management Zwischenprodukte für die herstellung von neuraminidase-inhibitor-konjugaten
RU2237470C1 (ru) * 2003-01-27 2004-10-10 Купсин Евгений Вениаминович Комбинированный препарат для устранения симптомов простудных заболеваний и гриппа (варианты)
TWI546306B (zh) * 2007-04-11 2016-08-21 第一三共股份有限公司 神經胺酸衍生物之製造方法
CN102532080A (zh) * 2010-12-29 2012-07-04 中国科学院上海药物研究所 新型唾液酸衍生物及其制备方法,包含该衍生物的药物组合物,以及其用途
EP2678324A1 (en) * 2011-02-24 2014-01-01 Cadila Healthcare Limited Process for the preparation of zanamivir
RU2520836C1 (ru) * 2013-02-27 2014-06-27 Александр Васильевич Иващенко (3r,4r,5s)-4-амино-5-(2,2-дифторацетиламино)-3-(1-этилпропокси)-циклогекс-1-енкарбоновая кислота и ее эфиры, способ их получения и применения
CN117243852A (zh) * 2023-11-01 2023-12-19 华熙生物科技股份有限公司 一种皮肤外用组合物及其用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2000786C1 (ru) * 1989-07-25 1993-10-15 Научно-исследовательский институт экспериментальной медицины РАМН Противовирусное средство при гриппозной инфекции
AP249A (en) * 1990-04-24 1993-03-17 Biota Scient Management Pty Ltd Anti-viral compounds.
RU2032683C1 (ru) * 1991-07-02 1995-04-10 Андрейчиков Юрий Сергеевич 2-метил-5-метокси-3-метоксалилацетобензофуран, проявляющий противовирусную активность в отношении вируса гриппа типа а и в
CA2081068C (en) * 1991-10-23 2005-11-29 Laurence Mark Von Itzstein Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of .alpha.-d-neuraminic acid
RU2030412C1 (ru) * 1992-03-04 1995-03-10 Иркутский институт органической химии СО РАН Способ получения 2-формил-2,5- дибутилтио-2,3- дигидро-4h-пирана
AUPM354694A0 (en) * 1994-01-27 1994-02-17 Biota Scientific Management Pty Ltd Chemical compounds

Also Published As

Publication number Publication date
AU723994B2 (en) 2000-09-07
NZ334101A (en) 2001-07-27
DE69721553D1 (de) 2003-06-05
EP0934939A1 (en) 1999-08-11
RU2169145C2 (ru) 2001-06-20
KR100526666B1 (ko) 2005-11-08
NO990672D0 (no) 1999-02-12
CN1232461A (zh) 1999-10-20
CZ293041B6 (cs) 2004-01-14
WO1998006712A1 (en) 1998-02-19
CN1126752C (zh) 2003-11-05
IL128358A0 (en) 2000-01-31
DK0934939T3 (da) 2003-07-21
PT934939E (pt) 2003-07-31
HUP9903632A2 (hu) 2001-08-28
CZ36599A3 (cs) 1999-06-16
DE69721553T2 (de) 2004-07-22
ES2198002T3 (es) 2004-01-16
NO319321B1 (no) 2005-07-11
AU3785897A (en) 1998-03-06
EP0934939A4 (enExample) 1999-09-15
IL128358A (en) 2003-04-10
EP0934939B1 (en) 2003-05-02
CA2263336C (en) 2007-03-13
CA2263336A1 (en) 1998-02-19
KR20000029971A (ko) 2000-05-25
HK1022687A1 (en) 2000-08-18
HU226130B1 (en) 2008-05-28
HUP9903632A3 (en) 2002-04-29
NO990672L (no) 1999-04-13

Similar Documents

Publication Publication Date Title
ATE239006T1 (de) Verbindungen der neuraminsaeure
NO950297D0 (no) Prolinamidderivater
NL960012I1 (nl) Gesubstitueerde acylderivaten van 1,2,3,4-tetrahydro-6,7-dimethoxy-3-isochinolinecarbonzuur.
MX9202142A (es) Nuevos derivados de urea, proceso para su preparacion, y composicion farmaceutica que los comprende.
DE69732571D1 (de) Beta-sulfonyl-hydroxamsäuren als matrix-metalloproteinaseinhibitoren
IL121305A0 (en) Neuraminic acid derivatives and pharmaceutical compositions containing the same
DK1031569T3 (da) Salt af et 7-isoindolinquinoloncarboxylsyre-derivat, monohydrat deraf og sammensætning, der indeholder dette som aktiv bestanddel
PT916651E (pt) DERIVADOS DE áCIDO FENILALQUILCARBOXILICO
PT1043310E (pt) Derivados de bifenilamidina
DK1157998T3 (da) Heterocykliske forbindelser, mellemprodukter derfor og elastaseinhibitorer
ATE223411T1 (de) 1-methylcarbapenem-derivate
DE60002558D1 (de) Derivate der Phosphonsäure zur Inhibierung von Carboxypeptidase B
EA200100967A1 (ru) Новое иммунодепрессивное средство
ATE171622T1 (de) Antiallergische zusammensetzung enthaltend eine phosphorsäurediester-verbindung
DE69203164D1 (de) Vorbeugende/therapeutische Zusammensetzung für die Pleuropneumonie des Schweins.
EP0450232A3 (en) P-guanidino benzoic acid derivatives for treatment of cerebrovascular contraction

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0934939

Country of ref document: EP

EEIH Change in the person of patent owner